| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |